This compound is a chiral benzoxazole-diazepane derivative that functions as an orexin receptor antagonist. It is primarily supplied as an active pharmaceutical ingredient for research and manufacturing purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Suvorexant metabolite M9
pharmaceutical raw material
(R)-(-)-1-Aminoindane hydrochloride
pharmaceutical raw material
(2R)-daptomycin
pharmaceutical raw material
Tribenoside
pharmaceutical raw material
Levamlodipine
pharmaceutical raw material
Suvorexant
pharmaceutical raw material
[(7S)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
JYTNQNCOQXFQPK-INIZCTEOSA-N
C[C@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.